← Back to Search
Nanotechnology For Targeted Cancer Therapy
M. Wang, D. Shin, J. Simons, Shuming Nie
Published 2007 · Medicine
Download PDFAnalyze on Scholarcy
Cancer nanotechnology is currently under intense development for applications in cancer imaging, molecular diagnosis and targeted therapy. The basic rationale is that nanometer-sized particles, such as biodegradable micelles, semiconductor quantum dots and iron oxide nanocrystals, have functional or structural properties that are not available from either molecular or macroscopic agents. When linked with biotargeting ligands, such as monoclonal antibodies, peptides or small molecules, these nanoparticles are used to target malignant tumors with high affinity and specificity. In the ‘mesoscopic’ size range of 5–100 nm in diameter, nanoparticles also have large surface areas and functional groups for conjugating to multiple diagnostic (e.g., optical, radioisotopic or magnetic) and therapeutic (e.g., anticancer) agents. Recent advances have led to multifunctional nanoparticle probes for molecular and cellular imaging, nanoparticle drugs for targeted therapy, and integrated nanodevices for early cancer detection and screening. These developments have opened exciting opportunities for personalized oncology in which cancer detection, diagnosis and therapy are tailored to each individual’s molecular profile, and also for predictive oncology, in which genetic/molecular information is used to predict tumor development, progression and clinical outcome.
This paper references
Transport of molecules, particles, and cells in solid tumors.
R. Jain (1999)
Molecular cancer therapeutics: recent progress and targets in drug resistance.
T. Tsuruo (2003)
Caveolae: mining little caves for new cancer targets
Lucy A. Carver (2003)
Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy.
The dawning era of polymer therapeutics
R. Duncan (2003)
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
M. Harisinghani (2003)
Tumor Regression by Targeted Gene Delivery to the Neovasculature
J. Hood (2002)
Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture.
S. Bennis (1994)
Resistance mechanisms associated with altered intracellular distribution of anticancer agents.
A. Larsen (2000)
Chemical approaches to triggerable lipid vesicles for drug and gene delivery.
Xin Guo (2003)
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Rajni Sinha (2006)
HLA-B27 and disease pathogenesis: new structural and functional insights.
P. Bowness (1999)
Design of folic acid-conjugated nanoparticles for drug targeting.
B. Stella (2000)
Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.
A. C. de VerdiÃ¨re (1997)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
Understanding barriers to drug delivery: high resolution in vivo imaging is key.
R. K. Jain (1999)
A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors
R. Hardman (2006)
Nanoparticles – known and unknown health risks
P. Hoet (2004)
Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs.
M. Links (1999)
The potential environmental impact of engineered nanomaterials
V. Colvin (2003)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
caCORE: A common infrastructure for cancer informatics
P. Covitz (2003)
Polymer conjugates: nanosized medicines for treating cancer.
M. Vicent (2006)
Albuminbound paclitaxel in metastatic breast cancer
DM Robinson (2006)
• Provides an excellent description of ligands and technologies explored for tumor targeting. Includes information on antibodies, immunoliposomes, immunotoxins and immuno-polymer conjugates
C. P. Leamon (2004)
Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis
R. Kannagi (2004)
• Critical review paper that stimulated the field of polymer-anticancer conjugates
Nanosizing: a formulation approach for poorly-water-soluble compounds.
E. Merisko-Liversidge (2003)
caBIONet - A .NET wrapper to access and process genomic data stored at the National Cancer Institute's Center for Bioinformatics databases
P. Kraj (2005)
Endogenous lectins as targets for drug delivery.
N. Yamazaki (2000)
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
Chemical Approaches to Triggerable Lipid Vesicles for Drug and Gene Delivery
Xin Guo (2003)
Nanotechnology: Opportunities and Challenges
M. Meyyappan (2003)
Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs.
E. K. Park (2005)
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.
C. Vauthier (2003)
Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.
R. Krishna (2000)
A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.
Ahmed M. Mansour (2003)
Folate-mediated targeting: from diagnostics to drug and gene delivery.
C. P. Leamon (2001)
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
Emerging use of nanoparticles in diagnosis and treatment of breast cancer.
M. Yezhelyev (2006)
Ligand-targeted therapeutics in anticancer therapy
T. Allen (2002)
Outstanding review on the roles of caveolins for targeting imaging and therapeutic agents into solid tumors
Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.
S. Moghimi (2000)
Structure and properties of pharmacologically active polymers
H. Ringsdorf (2007)
D. Robinson (2012)
Targeting cancer cells by exploiting their resistance.
M. V. Blagosklonny (2003)
In vivo molecular and cellular imaging with quantum dots.
X. Gao (2005)
The origin of pegnology.
F. F. Davis (2002)
Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function.
R. Jain (2001)
This paper is referenced by
Radiolabelled Nanoparticles for Diagnosis and Treatment of Cancer
Dimple Chopra (2011)
Intravitreal nanoparticles for retinal delivery.
Xiao-nan Huang (2019)
Amyloid hybrid membranes for removal of clinical and nuclear radioactive wastewater
Sreenath Bolisetty (2020)
Stark fluoreszierende halbleitende Polymerpunkte für Biologie und Medizin
C. Wu (2013)
Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance
Hoda Soleymani Abyaneh (2018)
Anti-Candidal Activity and In Vitro Cytotoxicity Assessment of Graphene Nanoplatelets Decorated with Zinc Oxide Nanorods
G. Ficociello (2018)
Nanotechnology in Dermatology*
J. Antonio (2014)
Multiscale modeling and uncertainty quantification in nanoparticle-mediated drug/gene delivery
Y. Li (2014)
Injectable Multistage Nanovectors for Enhancing Imaging Contrast and Directed Therapy
B. Godin (2012)
Development of an In Vivo Assay for Antibody-Conjugated Gold Nanoparticles Targeted to Human Pancreatic Tumor Xenografts Using an Ex Ovo Avian Embryo Culture System
Ilana B. Pollack (2013)
Highly fluorescent semiconducting polymer dots for biology and medicine.
C. Wu (2013)
Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
Alja Zottel (2019)
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Phatsapong Yingchoncharoen (2016)
Synthesis and morphology of triangular pyramid-shaped puerarin microparticle with nanostructure
Chuan Hua Lu (2010)
Role of Antibodies in Cancer Treatment (An Overview)
H. Albrecht (2010)
Intramolecular and intermolecular crosslinked poly(vinyl alcohol)–borate complexes for the sustained release of fertilizers and enzymes
S. Kale (2011)
Endoplasmic reticulum-targeted phototherapy using one-step synthesized trace metal-doped carbon-dominated nanoparticles: Laser-triggered nucleolar delivery and increased tumor accumulation.
Yan-Wen Bao (2019)
BIOLOGICAL SYNTHESIS AND CHARACTERIZATION OF GOLD NANOPARTICLES USING LEMNA MINOR
U. Saraswathi (2014)
Cardiovascular nanomedicine: Challenges and opportunities
B. Godin (2012)
Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.
Xiang-hong Peng (2011)
A new dawn for the use of traditional Chinese medicine in cancer therapy
H. Parekh (2008)
Design and synthesis of multifunctional poly(ethylene glycol)s using enzymatic catalysis for multivalent cancer drug delivery
K. S. Seo (2012)
Cardiovascular nanomedicine: a posse ad esse.
B. Godin (2012)
The internalization of fluorescence-labeled PLA nanoparticles by macrophages.
Fengjuan Li (2013)
Application of Chitosan-Based Nanocarriers in Tumor-Targeted Drug Delivery
Mohammad Ali Ghaz-Jahanian (2014)
Polymeric nanoparticles for cancer therapy
S. Parveen (2008)
Iron Oxide-Based Polymeric Magnetic Nanoparticles for Drug and Gene Delivery: In Vitro and In Vivo Applications in Cancer
S. Yalçın (2019)
Nanoparticle therapeutics for prostate cancer treatment.
V. Sanna (2012)
Nanomedicine in Cancer Diagnosis and Therapy: Converging Medical Technologies Impacting Healthcare
M. Thanou (2014)
Molecular nanomedicine towards cancer: ¹¹¹In-labeled nanoparticles.
D. Psimadas (2012)
Surface functionalized amorphous nanosilica and microsilica with nanopores as promising tools in biomedicine
A. Rahman (2008)
Targeted drug delivery for treatment and imaging of glioblastoma multiforme
Jill M. Stukel (2009)See more